The cluster is too small relative to market cap to carry a directional signal. The $24.8M in insider buying over the prior 30 days (likely from the IPO lockup expiry or option exercises) dominates this $1.89M sell cluster. Monitor for any C-suite selling or larger director sales exceeding 0.5% of market cap before assigning bearish weight.
CGON drugs
CGON drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jul 20 $70.19entry
- T+1 · 4mo ago +2.18%α +1.35% · $71.72
- T+5 · 4mo ago +4.74%α +5.15% · $73.52
- T+20 · 3mo ago +9.86%α +5.74% · $77.11
- T+60 · 5w ago −11.10%α −15.94% · $62.40
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two CG Oncology directors sold a combined $1.89M in stock over a 7-day window, with the bulk ($1.82M) sold by director James Mulay at $75.16. The total sales represent ~0.03% of the $6.3B market cap, falling well below the 0.1% materiality threshold. Director Leonard Post's sale was a same-day exercise-and-sell of 1,000 shares at $71.17, a routine cashless exercise pattern. The dollar amounts are trivial relative to company size, making this cluster non-informative despite the cross-filing amplifier signals.
Key Financial Metrics
Key Facts
- Director James Mulay sold 24,200 shares for $1.82M at $75.16 on 2026-07-10
- Director Leonard Post sold 1,000 shares for $71,170 at $71.17 on 2026-07-15, after exercising derivatives for $600 and $0
- Total cluster value of $1.89M represents ~0.03% of CGON's $6.3B market cap
- No C-suite executives traded; both sellers are directors
- Recent insider activity (30d) shows $24.8M in buys vs $2.2M in sells, indicating net buying by other insiders
Financial Impact
Total insider sales of $1.89M, or ~0.03% of market cap, immaterial
Risk Factors
- Small sample, only 2 directors sold, no C-suite participation
- Post's sale is a routine cashless exercise (derivative exercise + immediate sale) with no informational content
- Cross-filing amplifier signals are statistically significant but the absolute dollar amount is too small to trigger a materiality override
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-CGON-1784354556299 |
Track record
25 reports on CGON
6 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +26.33% at T+20 after the Jun 12, 2026 report. 8 of 8 went positive at some point.
Filters
- Nov 16, 2026today 8-K Bullish 7/10 Entry $98.84 Now $84.78 −14.23% settles Dec 15
- Nov 16, 2026today Press Release Bullish 7/10 Entry $95.01 Now $84.78 −10.77% settles Dec 15
- Nov 6, 202610d ago 8-K Bearish 5/10 Entry $75.99 Now $84.78 −11.57% settles Dec 7
- Nov 6, 202610d ago Press Release Neutral 4/10 Entry $75.99 Now $84.78 +11.57% settles Dec 7
- Nov 3, 202613d ago Institutional Cluster Neutral 3/10 Entry $64.06 Now $84.78 +32.34% settles Dec 2
- Oct 19, 202628d ago 3 Neutral 2/10 Entry $61.93 Now $84.78 +36.90% settles Nov 17
- Oct 15, 20264w ago 144 Neutral 2/10 Entry $59.85 to $74.40 Now $84.78 +41.65% ▲ +24.31% +25.47% vs SPY
- Oct 12, 20265w ago Institutional Cluster Mixed 3/10 Entry $63.13 to $74.74 Now $84.78 +34.29% ▲ +18.39% +21.66% vs SPY
- Aug 6, 202614w ago Press Release Bearish 7/10 Entry $74.85 to $74.33 Now $84.78 −13.27% ▲ +0.69% +1.29% vs SPY
- Aug 6, 202614w ago 424B5 Bearish 6/10 Entry $74.85 to $74.33 Now $84.78 −13.27% ▲ +0.69% +1.29% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers